All eyes will be on the latest US consumer price data and the Chancellor's Spring statement on Tuesday.
AIM-quoted mineral exploration company Salt Lake Potash has signed a memorandum of understanding with gold mining firm Blackham Resources on the potential development of a potash sulphate project in Australia.
Cancer drug development company Hutchison China Meditech plans to gain approval for its fruquintinib drug as China’s first Tyrosine-Kinase inhibitor (TKI), the company said on Monday.
President Energy announced the results of recent reactivation testing of gas wells in Argentina on Monday, noting a live gas field with potentially commercial gas flows.
African Battery Metals (ABM) announced on Monday that it will increase focus on its cobalt projects at its Kisinka licence in the Democratic Republic of Congo (DRC).
Technical training solutions company Pennant International reported a decrease in profits for 2017 on Monday, despite achieving revenue growth over the year.
Ariana Resources announced on Monday that it expects its Kiziltepe project in Turkey to produce 20,000 ounces of gold in 2018, an increase of 47% over 2017.
Shares of E. ON and RWE were catapulted higher by news of a multi-billion pound asset swap aimed at fending off the entry of European rivals into their main market.
Point-of-sale, payment and online loyalty systems developer and supplier Universe Group has installed its next-generation point-of-sale, back office and head office solution in its 70th site for petrol forecourt operator Rontec, it announced on Monday.
Turnaround specialist Melrose Industries has upped its offer for engineer GKN to 467p per share, or £8. 1bn, from £7. 4bn.
Cloud-based software-as-a-service (SaaS) accounting software provider FreeAgent Holdings announced the appointment of Nick Longden as vice-president of sales on Monday, to help spearhead its growth strategy within its accounting practice division.
Product testing, inspection and certification company, Intertek, has acquired Malta-based quality and quantity cargo inspection services provider Aldo Abela Surveys (AAS) for an undisclosed sum.
Cancer treatment prediction technology provider Physiomics has successfully completed the Innovate UK grant project announced in January last year, it announced on Monday.
Radiation detection technology company Kromek has been awarded an extension to its high-volume production contract with the Defense Advanced Research Projects Agency (DARPA), an agency of the US Department of Defense, initially awarded in February 2016.
Clinical-stage pharmaceutical company Diurnal saw losses widen in the first half of its trading year as costs rose ahead of the launch of its maiden product.
Trading of virtual reality technology company VR Education's shares began in London and Ireland on Monday morning after the firm raised a total of £6m, rising more than 17% on debut.
Biogen has agreed to buy a phase 2b trial-ready schizophrenia treatment from Pfizer for up to $590m.
Generic drug-maker Hikma Pharmaceuticals will carry out a clinical trial of its generic version of GlaxoSmithKline's Advair Diskus asthma drug after consultation with the US drug regulator.
Eve Sleep said on Monday that it's aiming to be profitable in the UK this year, as it reported a widening of its losses in 2017.
Shares in optical components manufacturer Oclaro surged in pre-market trade on Monday as it agreed to be bought by Lumentum Holdings, a provider of photonics products, for $1. 8bn.